Home / Compounds / Tesamorelin

Tesamorelin

Body Composition

Visceral fat reduction and GH stimulation.

Athletic Use Cases
Visceral Fat ReductionGH Axis SupportBody CompositionCardiovascular Health
WADA Status
WADA Banned
Standard Dose
1mg - 2mg
Frequency
Daily
Half-Life
~26 minutes

Athletic Mechanism of Action

GHRH analog that stimulates pituitary GH release, leading to IGF-1 elevation and visceral fat reduction.

For athletes, the primary value of Tesamorelin lies in its ability to visceral fat reduction and gh stimulation.. This mechanism is particularly relevant during high-volume training phases when tissue repair demand exceeds the body's natural recovery capacity.

Recovery Timeline

12–16 weeks for significant visceral fat reduction

Individual response varies based on injury severity, training load, and baseline health markers.

WADA Compliance Status

WADA Banned FDA Approved

Well studied. Can cause fluid retention, joint pain. Contraindicated in active malignancy.

Always verify current WADA status with your sport's governing body before use in competition.

Research Evidence

Primary Study

https://pubmed.ncbi.nlm.nih.gov/20592731/

Supporting Evidence

https://pubmed.ncbi.nlm.nih.gov/22032314/

Clinical Protocol

Start a Tesamorelin Protocol

Hatter Labs provides physician-supervised performance protocols with GMP-certified Tesamorelin and comprehensive biomarker monitoring.

Get Protocol
Physician-Supervised Performance

Start Your Performance Protocol for Tesamorelin

Hatter Labs provides physician-supervised performance protocols with GMP-certified compounds, biomarker testing, and personalized programs designed around your training goals.

HIPAA Compliant · GMP Certified · Physician Supervised